Combination treatment of rituximab and donor platelets infusion to reduce donor‐specific anti‐HLA antibodies for stem cells engraftment in haploidentical transplantation

BACKGROUND: Donor‐specific anti‐human leukocyte antigen (HLA) antibodies (DSAs) in recipients is a risk factor for donor stem cell graft failure in haploidentical hematopoietic stem cell transplantation (haplo‐HSCT), and the treatment to reduce the levels of DSAs is not unanimous. This study was to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Lab Anal
Autori principali: Zhang, Rongli, He, Yi, Yang, Donglin, Jiang, Erlie, Ma, Qiaoling, Pang, Aiming, Zhai, Weihua, Wei, Jialin, Feng, Sizhou, Han, Mingzhe
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370703/
https://ncbi.nlm.nih.gov/pubmed/32112480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23261
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi